We compared the differentially expressed genes identified in ZNF217 overexpressing ovarian cancer cell lines to a previously published dataset of direct ZNF217 targets in the breast cancer cell line MCF7 and identified that there was significant overlap between them (Fig. 4C)26. This evidence concerns the gene ZNF217 and ovarian carcinoma.